$CURR should return banner performance in 2021 wit
Post# of 40256
(Total Views: 56)
Posted On: 02/01/2021 12:08:18 PM
Re: trooperstocks #24733
$CURR should return banner performance in 2021 with all the accomplishments reported to date. The company's biopharma facilities are operating at the highest standards for the production of multiple healthcare products lines all optimized for enhanced bio-delivery to ensure peak effectiveness.
CURE Pharmaceutical(R) is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF(R) and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
CURE Pharmaceutical(R) is the pioneering developer of CUREform(TM), a patented drug delivery platform that offers a number of unique immediate- and controlled-release drug delivery vehicles designed to improve drug efficacy, safety, and patient experience for a wide range of active ingredients.
As a vertically integrated company, CURE's 25,000 square foot, FDA-registered, NSF(R) and cGMP-certified manufacturing facility enables it to partner with pharmaceutical and wellness companies worldwide for private and white-labeled production. CURE has partnerships in the U.S., China, Mexico, Canada, Israel, and other markets in Europe.
(0)
(0)Scroll down for more posts ▼